CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 674094-674219 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"In conclusion, Fexofenadine was the only AH found to be non-impairing in all studies, even at double the recommended US dose.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T49492","span":{"begin":0,"end":125},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T49492","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"Epistemic_Statements","denotations":[{"id":"T1125","span":{"begin":0,"end":125},"obj":"Epistemic_statement"}],"attributes":[{"subj":"T1125","pred":"source","obj":"Epistemic_Statements"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T394","span":{"begin":0,"end":125},"obj":"Sentence"}],"attributes":[{"subj":"T394","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T6224","span":{"begin":28,"end":31},"obj":"Disease"}],"attributes":[{"id":"A6224","pred":"mondo_id","subj":"T6224","obj":"http://purl.obolibrary.org/obo/MONDO_0010518"},{"subj":"T6224","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec93bd","default":true},{"id":"Epistemic_Statements","color":"#93d7ec"},{"id":"CORD-19_Custom_license_subset","color":"#ece793"},{"id":"CORD-19-PD-MONDO","color":"#cd93ec"}]}]}}